Introduction
============

Cellulose, composed of repeating glucose units connected by β-([@b1-mmr-19-01-0452],[@b4-mmr-19-01-0452])-glycosidic bonds, is one of the most abundant among the many natural polymers and is one of the major organic compounds found in plant cell walls ([@b1-mmr-19-01-0452],[@b2-mmr-19-01-0452]). Due to its white fiber-like structure, no odor and a density of \~1.5, cellulose and its derivatives are commonly used as drug coating materials, blood coagulants, artificial kidney membranes, antitumor drugs, blood-compatible materials, and supports for immobilized enzymes ([@b3-mmr-19-01-0452]--[@b7-mmr-19-01-0452]). Furthermore, no special treatments are required for eliminating risk factors such as immune response and viral risk, which are observed after chitosan treatment ([@b8-mmr-19-01-0452]--[@b11-mmr-19-01-0452]). Cellulose membranes have especially been applied in medical devices such as dialysis machines and biosensors, while bioadhesive cellulose gels have an application in bone tissue engineering and connective tissue formation ([@b12-mmr-19-01-0452]). However, very little is known about the possibility of LB prepared with cellulose powders originating from the different natural sources such as marine animals and plants.

LB is a chemical mixture which forms a thin polymeric layer on the skin; this characteristic has found a use as a topical skin treatment for minor cuts and sores ([@b13-mmr-19-01-0452]). In humans, it stimulates the skin wound repair by retaining an adequate moisture balance and protecting the wound from infections ([@b10-mmr-19-01-0452],[@b14-mmr-19-01-0452]). Extensive preparations of liquid bandage (LB) using various other polymers have been used, including polyvinylpyrrolidone, ethyl cellulose, pyroxylin/nitrocellulose, poly (methylacrylate-isobutene-monoisopropylmaleate), and acrylate or siloxane polymers ([@b13-mmr-19-01-0452]). 2-octyl-cyanoacrylate is the most common polymer for preparing LB applied to cornea, sclera, eyelid skin grafts, and mucous membrane grafts during socket reconstruction, and for temporary treatment of myopathic blepharoptosis after botulinum toxin injection ([@b15-mmr-19-01-0452]--[@b19-mmr-19-01-0452]). Studies involving cellulose as a polymer material for LB preparation are limited; only one previous study attempted application of nano-porous nitrocellulose LB for wound healing, and presented the physicochemical properties and therapeutic effects on cutaneous wound healing in an ICR model ([@b10-mmr-19-01-0452]).

In the current 12-day study, we evaluated the efficacy of on healing cutaneous wounds and toxicity in Sprague Dawley rats after application of LB prepared with cellulose powders from *Styela clava* tunics (SCT) and *Broussonetia kazinoki* bark (BSLB). The results of this study provide strong evidence that BSLB is a promising wound dressing due to its acceptable properties for healing wounds and non-toxicity in the injured skin of Sprague Dawley rats.

Materials and methods
=====================

SCT powder was prepared as previously described ([@b20-mmr-19-01-0452]). Briefly, SCT were collected from the beach of the South Sea in Gosung-gun, Korea, and voucher specimens of LP (WPC-14-002) were deposited at the Functional Materials Bank of the PNU-Wellbeing RIS Center in Pusan National University (Miryang, Korea). Sediments and debris were removed by boiling SCT (33 g) in 10% NaOH (Daejung Co., Gyeonggi-do, Korea) aqueous solution (990 ml) at 100°C for 2 h. Samples were subsequently washed three times with distilled water, boiled in 5% CH~3~COOH (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) solution at 100°C for 2 h to neutralize the NaOH solution, and washed thrice in distilled water. SCT was subsequently bleached by boiling and washing separately in 10% H~2~O~2~ (Junsei Co., Tokyo, Japan) solution. After a final wash with distilled water, the resulting SCT was dried at 100--120°C for 2--3 h, followed by grinding in a pin mill machine (Daehwa Co., Goyang, Korea). The milling for SCT powder was conducted by a proprietary commercial process which involved passing through a combination of 30 mesh sieve for 10 min once, and then sieved twice through 120 mesh for 10 min each.

BKB were collected from the cultivation area in Imshil-Gun, Korea, and voucher specimens of LP (WPC-15-001) were deposited at the Functional Materials Bank of the PNU-Wellbeing RIS Center in Pusan National University. Briefly, BKB were heated at 20°C for 10 min and cooled to 1°C for 1 min. They were then boiled in 5% NaOH and 10% Na~2~CO~3~ (Junsei Co.) solution (1,000 ml) at 95°C for 1 h, followed by washing with tap water for 20 min. This step was repeated with 2% NaOH and 3% Na~2~CO~3~ solution (1,000 ml) using the same conditions. After a final wash with distilled water, the BKB was dried at 100--120°C for 2--3 h, before grinding in a pin mill machine (Daehwa Co.).

BSLB was prepared using a modified version of the method described in a previous study ([@b20-mmr-19-01-0452]). To manufacture high concentration BSLB (HiBSLB), 1.5 g of SCT powder and 1.5 g of BKB powder were completely dissolved in 100 ml of \[Amim\]Cl ionic liquid composed of 1-methylimidazole (Daejung Co.) and 3-chloro-1-propene (Sigma-Aldrich; Merck KGaA; 1:1.20 of molar ratio) at 80°C. The low concentration BSLB (LoBSLB) was prepared by diluting HiBSLB (4.3 ml) in 25.17 ml of \[Amim\]Cl ionic liquid before use ([Fig. 1](#f1-mmr-19-01-0452){ref-type="fig"}).

### Design of animal experiment

The animal protocol used in this study was reviewed and approved by the Pusan National University-Institutional Animal Care and Use Committee (PNU-IACUC; approval no. PNU-2015-0972). Adult male Sprague Dawley rats were purchased from Samtako BioKorea (Osan, Korea), and handled at the Pusan National University Laboratory Animal Resources Center accredited by the Korea Food and Drug Administration (accredited unit no. 00231) and AAALAC International (accredited unit no. 001525). All rats were provided with a standard irradiated chow diet (Purina Mills, Seoungnam, Korea) *ad libitum*, and were maintained in a specific pathogen-free (SPF) state under a strict light cycle (lights on at 06:00 h and off at 18:00 h) at a temperature of 23±2°C and a relative humidity of 50±10%.

An *in vivo* wound healing assay was developed, in which seven-week-old Sprague Dawley rats (n=20) were assigned to one of four groups: Vehicle (gauze, GZ)-treated group (n=5); Medifoam liquid bandage (MFLB)-treated group (n=5); LoBSLB-treated group (n=5); and HiBSLB-treated group (n=5). MFLB as a positive control bandage was purchased from Mundipharma (Seoul, Korea). Briefly, animals were anesthetized by intramuscular injection with Zoletile (50 mg/kg body weight) and Rompun (5 mg/kg body weight). Appropriate anesthesia of all rats was monitored by pedal reflex which clamps the tail or the transitional skin of the rat with forceps and corneal reflex that touches the cornea with watery cotton. After, the back skins were shaved with an electrical razor and cleaned with 70% ethanol. Using a biopsy punch (Kasco Co., Sialkot, Pakistan), a round wound of 8 mm diameter and 2--4 mm depth was created by removing the cutaneous tissue in the back shoulder region. The incision wound on each rat was sterilized with 70% ethanol, after which it was treated with GZ, MFLB, LoBSLB or HiBSLB. The pieces (5×4×0.3 mm) of GZ and the three types of LB were replaced every 4 days. During replacement, the condition of the skin wound was observed and photographed with a Canon^®^ digital camera, while the body weight was measured using an electronic balance (Mettler Toledo, Greifensee, Switzerland). After 12 days, all rats were euthanized using carbon dioxide (CO~2~) according to the AVMA Guidelines for the Euthanasia of Animals: 2013 Edition (gradual filling at verified 10--30% displacement rate/min). During this process, CO~2~ gas was introduced into the 18.74 l euthanasia chamber at a flow rate of 3.7 l/min of (20% chamber volume/min). Successful euthanization in rats was confirmed by the measurement of several biological signals including heartbeat, movement, breathing and pupillary response to light. The samples of the damaged skin were collected for further histological and western blot analysis. Additionally, blood serum from the abdominal veins, and liver and kidney tissues were collected to analyze the toxicity of the two BSLBs.

### Macroscopic analyses of the surgical wounds

Photographic data were used for measuring the wound size (%), which was calculated as follows:

Wound size (%) = $$\frac{\mathbf{W}\mathbf{t}}{\mathbf{W}0}$$

where Wt is the wound area at time 't' and W~0~ is the wound area at the initial time. A multiple comparisons test was performed for clarifying the statistical difference between groups.

### Serum biochemistry

At day 12, all animals were fasted for 8 h, after which blood was collected from the abdominal veins of rats and incubated for 30 min at room temperature. Serum was obtained by centrifugation the whole blood, and serum biochemical components, including alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and creatinine (CREA), were assayed using an automatic serum analyzer (Hitachi 747; Hitachi Ltd., Tokyo, Japan). All assays were measured in duplicate using fresh serum.

### Histological analyses

The site of application on the cutaneous wound region was collected and fixed in 10% formalin for 48 h, embedded in paraffin wax, and sectioned into 4 µm thick slices. The skin sections were subsequently stained with hematoxylin and eosin (H&E; Sigma-Aldrich; Merck KGaA) and examined by light microscopy for the presence of edema and inflammatory cell accumulation. Additionally, re-epithelialization and thickness of the epidermis were measured using the Leica Application Suite (Leica Microsystems, Wetzlar, Germany). The liver and kidneys collected from all experimental rats were processed using the same protocol applied to treat the skin tissue, and pathological changes were examined after H&E staining, using the Leica Application Suite (Leica Microsystems).

### Western blot analysis

Granulated wound skin tissue were isolated from a subset of groups, homogenized using a PRO-PREP^™^ Solution kit (iNtRON Biotechnology, Sungnam, Korea) supplemented with half tablet of a protein inhibitor cocktail (Roche Applied Science, Penzberg, Germany), and the mixture was centrifuged at 13,000 rpm for 5 min. The prepared proteins were then electrophoresed on a 10% SDS-PAGE gel, following which they were transferred onto a nitrocellulose membrane (Amersham Biosciences, Corston, UK) for 2 h at 40 V in transfer buffer (25 mM Trizma-base, 192 mM glycine, and 20% methanol). The efficiency of the transfer and equal protein loading were determined by staining the membrane with Ponceau, while the gel was stained with Coomassie blue (both Sigma-Aldrich; Merck KGaA). Appropriate dilutions of the following primary antibodies were added to the membranes and allowed to hybridize overnight at 4°C: Anti-VEGF (PeproTech, Rocky Hill, New Jersey, USA), anti-EGFR (Abcam, Cambridge, UK), anti-p-EGFR (Cell Signaling Technology, Inc., Danvers, MA, USA), anti-collagen-1 (Abcam), anti-AKT, anti-phospho-AKT (both Cell Signaling Technology, Inc.), and anti-β-actin (Sigma-Aldrich; Merck KGaA). After removing the antibodies, the membrane was washed three times in a solution composed of 10 mM Trizma-base (pH 7.6), 150 mM NaCl (both Sigma-Aldrich; Merck KGaA), and 0.05% Tween-20 (Biosesang, Gyeonggi-do, Korea), for 10 min. The primary antibody conjugated membranes were then incubated with horseradish peroxidase-conjugated anti-secondary antibody for 1 h at room temperature. The membrane was washed again as described above, and developed using an enhanced chemiluminescence detection system (Amersham Biosciences). Finally, the results were quantified using the Image Analyzer System (Eastman Kodak 2000MM; Kodak, Rochester, NY, USA), and the results are expressed as the fold-increase over control values. All results were confirmed by two independent researchers conducting the experiments at least twice.

### Immunohistochemical analysis

Collagen distribution was detected by immunohistochemical analysis using light microscopy, as previously described ([@b21-mmr-19-01-0452]). Briefly, the wound skin tissue samples were fixed in 10% formalin for 48 h, embedded in paraffin, and sliced into 4 µm thick sections. These sections were subsequently deparaffinized with xylene, rehydrated, and pretreated for 30 min at room temperature with PBS blocking buffer containing 10% goat serum. The sections were then incubated with primary anti-collagen-1 antibody (Abcam) or anti-p-EGFR (Cell Signaling Technology, Inc.) diluted 1:300 in PBS blocking buffer. The antigen-antibody complexes were subsequently visualized with biotinylated secondary antibody (goat anti rabbit)-conjugated HRP streptavidin (Histostain-Plus kit; Zymed, South San Francisco, CA, USA) at a dilution of 1:1,500 in PBS blocking buffer. Finally, collagen proteins were detected using a stable DAB (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and the Leica Application Suite (Leica Microsystems). Also, the distribution of p-EGFR protein in skin section was analyzed in the same way using anti-p-EGF receptor antibody.

### Statistical analysis

One-way ANOVA (SPSS for Windows, Release 10.10, Standard Version; SPSS Inc., Chicago, IL, USA) followed by Tukey\'s post hoc test was used to identify significant differences between the Vehicle and the three LB-treated groups. All values are reported as the means ± SD, and P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Effect of BSLB treatments on wound closing process

To determine the stimulatory effects of BSLB on the healing process of wounded skin, a spherical area measuring 8 mm in diameter and 2--4 mm in depth was evaluated for wounded skin covered with LoBSLB and HiBSLB for 12 days. The most significant changes observed in the wound area occurred between days 4--12. In the LoBSLB-treated group, the wound area decreased 79% on day 4, 43% on day 8, and 47% on day 12, when compared to the Vehicle-treated group. Similar results were also observed in the HiBSLB-treated group, with complete disappearance of the wound on day 12 ([Fig. 2A and B](#f2-mmr-19-01-0452){ref-type="fig"}). Furthermore, the decrease in wound area in the MFLB-treated group was similar to the LoBSLB-treated group ([Fig. 2A and B](#f2-mmr-19-01-0452){ref-type="fig"}). These results suggest that enhanced healing ability of the cutaneous surgical wound is reasonably attributed to BSLB treatment.

### Effect of BSLB treatment on tissue regeneration of wounded skin

The alterations in tissue regeneration of the wounded skin was determined by the recovery of the epidermis, dermis and hyperdermis of the skin tissue of rats over the designated study duration (12 days). To measure the therapeutic effects of the BSLB on tissue regeneration in the surgical skin wounds, we measured the thickness of the epidermis and the width of re-epithelialization region in the Vehicle, MFLB, LoBSLB and HiBSLB-treated groups. We observed a significant increase in re-epithelialization in the LoBSLB and HiBSLB-treated groups relative to the Vehicle-treated group, with a greater increase rate in the LoBSLB group than the HiBSLB group ([Fig. 3A](#f3-mmr-19-01-0452){ref-type="fig"}). Additionally, a similar pattern was observed for the thickness of the total epidermis. After day 12 post-surgery, the thickness of the total epidermis was significantly enhanced by about 126 and 139% in the LoBSLB and MFLB-treated groups, respecrively, relative to the Vehicle-treated group; however, constant levels were maintained in the HiBSLB-treated group ([Fig. 4A and B](#f4-mmr-19-01-0452){ref-type="fig"}). To further determine if the therapeutic effects of BSLB were related with activation of EGFR, we examined for differences in the level of phosphorylation of EGFR in the wound skin of BSLB-treated groups. We observed a significant increase in levels in the HiBSLB-treated group, whereas other groups maintained a constant level ([Fig. 3B](#f3-mmr-19-01-0452){ref-type="fig"}). Also, a similar pattern was observed in the immunohistochemical analysis for p-EGFR ([Fig. 3C](#f3-mmr-19-01-0452){ref-type="fig"}). Taken together, these results suggest that BSLB treatment improves tissue regeneration and re-epithelialization in the skin tissue of Sprague Dawley rats through the stimulation of EGFR.

### Effect of BSLB on the angiogenesis signaling pathway in wounded skin

The effect of BSLB treatment on the angiogenesis signaling pathway in the dermis of wounded skin was evaluated by measuring the expression level of VEGF and a member of the downstream signaling pathway, in a subset of groups at day 12. On day 12, the expression of VEGF, an important signaling protein involved in both vasculogenesis and angiogenesis, dramatically decreased in the LoBSLB and HiBSLB-treated groups, as compared with Vehicle-treated group ([Fig. 5](#f5-mmr-19-01-0452){ref-type="fig"}). A similar decrease was observed in AKT phosphorylation, one of members of the VEGF downstream signaling pathway. The phosphorylation of AKT was lower in the LoBSLB and HiBSLB-treated groups, as compared to the Vehicle-treated group, on day 12. These effects were similarly observed in the MFLB-treated group ([Fig. 5](#f5-mmr-19-01-0452){ref-type="fig"}). These results therefore indicate that BSLB treatment induces the down-regulation of the angiogenesis signaling pathway during the late stage of the wound skin repair process by regulating the expression of VEGF and AKT phosphorylation.

### Effect of BSLB on the formation of connective tissue in wound skin

To evaluate the therapeutic effects of BSLB on the formation of connective tissue in the wounded skin, the expression level of collagen was measured in a subset of groups at different times. We observed a rapid increase in the expression of collagen-1 in the LoBSLB and HiBSLB-treated groups (169 and 137%, respectively) compared with the Vehicle-treated group ([Fig. 6A](#f6-mmr-19-01-0452){ref-type="fig"}). The wound skin tissue stained for immunohistochemical analysis also showed a similar trend. The collagen protein was densely stained around the dermis of the LoBSLB and HiBSLB-treated groups relative to the Vehicle-treated group ([Fig. 6B](#f6-mmr-19-01-0452){ref-type="fig"}). These findings indicate that BSLB treatment induces an enhancement in collagen during the late stage of the wounded skin repair process.

### Toxicity of BSLB

The toxicity of BSLB toward the liver and kidneys of Sprague Dawley rats was evaluated by investigating modifications in the metabolic enzymes (in the blood serum) and histopathology (of liver and kidney tissues), using serum biochemical analysis and histological analysis, respectively. Liver toxicity analysis revealed no increase in the levels of the three liver toxicity indicators, specifically ALP, AST and ALT, in both the LoBSLB and HiBSLB-treated groups and Vehicle-treated group. Also, no significant pathological changes such as inflammation, necrosis, apoptosis, or fibrosis were observed in the liver tissue of BSLB-treated groups ([Fig. 7](#f7-mmr-19-01-0452){ref-type="fig"}). Results for kidney toxicity were similar to the liver toxicity results. The BUN and CREA levels in the serum showed no significant increase in the two BSLB-treated groups, regardless of the dose administered. Furthermore, no specific pathological symptoms, including degeneration and necrosis of the glomerulus and renal tubes, were detected in the kidney tissue of the BSLB-treated groups ([Fig. 8](#f8-mmr-19-01-0452){ref-type="fig"}). The above results provide strong evidence that treatment with BSLB for a short duration does not induce any significant toxicity in the liver and kidneys of Sprague Dawley rats.

Discussion
==========

Various medical dressings have been extensively applied for treating external cutaneous wounds such as abrasions, lacerations, avulsions, puncture wounds, contusions, blisters, incisions, burns, split graft donor sites and ulcers ([@b22-mmr-19-01-0452]). LB has recently received a great deal of attention as a novel method of medical dressings for the treatment of various wounds, since it involves decreased trauma and eliminates the use of sutures and staples ([@b13-mmr-19-01-0452]). This study therefore attempted to obtain novel evidence for the potential medical applications of BSLB, and further investigated the therapeutic effects and toxicity in surgical cutaneous wounds of Sprague Dawley rats. Our results clearly indicate that BSLB accelerates the recovery of wounded skin, re-epithelialization, granular tissue formation, and angiogenesis, without any accompanying toxicity.

Our results demonstrate that BSLB treatment for 12 days stimulated wound closure in surgically injured skin of Sprague Dawley rats. Decrease in the wound area, as well as enhancement of re-epithelialization was strongly detected within 12 days of surgical injury, as presented in [Figs. 2](#f2-mmr-19-01-0452){ref-type="fig"} and [3](#f3-mmr-19-01-0452){ref-type="fig"}. These results were consistent with a previous study using topical application of nano-porous nitrocellulose LB. The cellulose significantly increased the wound closure as compared to the control group in ICR mice, although their change rate varied in each group ([@b10-mmr-19-01-0452]). These two studies therefore show that LB prepared with cellulose powder promotes the rate of cutaneous wound healing.

The current study further concludes that BSLB treatment accelerates the regeneration of surgical wound in the skin tissue of Sprague Dawley rats. As presented in [Figs. 3](#f3-mmr-19-01-0452){ref-type="fig"} and [4](#f4-mmr-19-01-0452){ref-type="fig"}, the re-epithelialization rate and thickness of epidermis is significantly enhanced in the LoBSLB-treated group compared with Vehicle-treated group. Similar results were obtained for surgical wounds in ICR mice-treated with nano-porous nitrocellulose LB, where application of the nitrocellulose LB onto surgical skin wounds exhibited enhanced wound re-epithelialization, contraction and granular tissue formation when compared with control-treated group ([@b10-mmr-19-01-0452]). However, the results obtained in the HiBSLB-treated group was dissimilar; we observed a constant level of epidermal thickening and only slight increase of re-epithelialization rate at day 12. Hence, we believe that LoBSLB treatment is more suitable for wound regeneration than HiBSLB treatment. The lower therapeutic effect of HiBSLB in wound regeneration could be a consequence of varying concentrations of components containing cellulose, even though cellulose was the basic building material.

Angiogenesis is an integral component of normal wound repair since it provides the nutrients required by the healing tissue and contributes to the structural repair by stimulating the formation of granulation tissue ([@b23-mmr-19-01-0452]). During angiogenesis, VEGF enhances the permeability, growth and migration of endothelial cells on the surface of a collagen matrix ([@b24-mmr-19-01-0452]--[@b26-mmr-19-01-0452]). This activity is also partially mediated via the MAPK2K1/2/MAPK3/1 or PI3K/AKT1 pathways ([@b27-mmr-19-01-0452]--[@b29-mmr-19-01-0452]). The expression of VEGF gradually elevates after full a thickness skin wound, and reaches maximal level at approximately days 3 to 7 during the period of granulation tissue formation. Once it reaches the remodeling phase, the VEGF signaling pathway gradually disappears ([@b30-mmr-19-01-0452]). Therefore, evaluating the decrease in the expression of key component of the VEGF signaling pathway can be considered a key marker indicating the effects of tissue repair. The decrease of VEGF expression has been widely examined after several therapeutic treatments for wound repair, although there are variations in the duration of observation. Topical application of Substance S significantly increased the wound closure and decreased VEGF expression at day 14 in rats with open excision wound ([@b31-mmr-19-01-0452]). The VEGF mRNA expression was down-regulated in all scars-treated with Ginsenoside-Rg3 (Rg3) compared to the control group ([@b32-mmr-19-01-0452]). Similarly, our study revealed decreased VEGF expression in the wound skin of LoBSLB and HiBSLB-treated groups.

Meanwhile, collagen is an important structural protein of the extracellular matrix and has a key role in all phases of surgical wound healing ([@b33-mmr-19-01-0452]). An improved deposition of collagen was reported in surgical wounded skin-treated with nano-porous nitrocellulose LB after Sirius Red staining ([@b10-mmr-19-01-0452]). In the present study, the expression of collagen increased in a dose dependent manner in the LoBSLB and HiBSLB-treated groups, as compared with the Vehicle-treated group, on day 12. These results are similar to previous studies, although the analysis tool was differed in each study.

The toxicity of LB prepared with cellulose powders has so far not been investigated in mammalian systems. However, toxicity for membrane forms prepared by cellulose mixtures are reported by several studies. Specific toxicity with respect to body weight or metabolic enzymes of the liver and kidney was not induced in the Sprague Dawley rats-treated with hydrocolloid membrane (HCM)-SCT for 11 days ([@b34-mmr-19-01-0452]). Also, the concentration of metabolic enzymes representing liver and kidney toxicity was maintained at a constant level in the serum of SCT-cellulose film (CF) implanted Sprague Dawley rats, relative to the vehicle implanted group ([@b20-mmr-19-01-0452]). Similar results for toxicity were also observed in our study using SCT and BKB. Most indicators of liver and kidney toxicity were maintained at a normal level in the LoBSLB and HiBSLB-treated groups throughout the experimental period. These results suggest that natural source cellulose can extensively be applied to surgical injuries without occurrence of any significant toxicity.

Taken together, the results of the present study indicate that topical application of two different concentrations of BSLBs for 12 days induces accelerated surgical wound healing, including tissue regeneration and connective tissue formation. The LoBSLB showed greater therapeutic effect of surgical wound healing of the back skin of Sprague Dawley rats. No significant toxicity was observed in the liver and kidneys of the experimental animals. Overall, these results serve as a rationale for future development of BSLB with other functional compounds, for topical application to cutaneous wounds.
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![Preparation and treatment of BSLB to the surgical wound injury. (A) BSLB was prepared by serial processing consisting of bleaching, neutralizing, milling, dissolving and mixing. (B) A cutaneous wound measuring 8 mm in diameter and 2--4 mm in depth was created by removing the skin tissue using a biopsy punch. These were treated with GZ, MFLB, LoBSLB or HiBSLB, which were replaced every 4 days. BSLB, liquid bandage; GZ, gauze; MFLB, medifoam liquid bandage; LoBSLB, low concentration BSLB; HiBSLB, high concentration BSLB.](MMR-19-01-0452-g01){#f1-mmr-19-01-0452}

![Healing pattern of wounded skin over a time period. At each time point, images of surgical wound skin of rats of each group were taken, and the morphological features were evaluated. (A) Macro-observation of experimental wound healing at various times post-surgery. (B) The ratio of wound area (%) to initial area on day 1 was measured over time. The wound size was measured in triplicate in each test. Five or six wounds were assayed in triplicate using the wound area analysis. Data are reported as the mean ± SD. \*P\<0.05 relative to the Vehicle-treated group; ^\#^P\<0.05 relative to the level of the MFLB group, ^§^P\<0.05 relative to the LoBSLB group. BSLB, liquid bandage; MFLB, medifoam liquid bandage; LoBSLB, low concentration BSLB; HiBSLB, high concentration BSLB.](MMR-19-01-0452-g02){#f2-mmr-19-01-0452}

![Re-epithelialization analysis after BSLB application. (A) H&E stained sections of subcutaneous tissue surrounding the applications of BSLB at day 12 were observed using a light microscope at a magnification, ×100. Five or six wounds were assayed in triplicate using wound area analysis. (B) Analysis of EGFR phosphorylation. Western blot analysis of EGFR, p-EGFR and β-actin in a homogenate mixture prepared from the wound skin was detected using the specific primary antibodies. (C) The distribution of p-EGFR were also observed in skin tissue at 400× magnification, after staining with p-EGFR antibody. Values are defined as 1 (Vehicle-treated group) for the acquisition of other relative values. Data are reported as the mean ± SD. \*P\<0.05 relative to the Vehicle-treated group; ^\#^P\<0.05 relative to the level of the MFLB group, ^§^P\<0.05 relative to the LoBSLB group. BSLB, liquid bandage; MFLB, medifoam liquid bandage; LoBSLB, low concentration BSLB; HiBSLB, high concentration BSLB; H&E, hematoxylin and eosin.](MMR-19-01-0452-g03){#f3-mmr-19-01-0452}

![Analysis of epidermal thickness after BSLB application. (A) H&E stained sections of subcutaneous tissue surrounding the two BSLB applications to Sprague Dawley rats at day 12 were observed using a light microscope at magnification, ×400. (B) Thickness was measured using the Leica Application Suite. Five or six wounds were assayed in triplicate using wound area analysis. Data are reported as the mean ± SD. \*P\<0.05 relative to the Vehicle-treated group; ^\#^P\<0.05 relative to the level of the MFLB group, ^§^P\<0.05 relative to the LoBSLB group. BSLB, liquid bandage; MFLB, medifoam liquid bandage; LoBSLB, low concentration BSLB; HiBSLB, high concentration BSLB; H&E, hematoxylin and eosin.](MMR-19-01-0452-g04){#f4-mmr-19-01-0452}

![Analysis of the downstream signaling pathway of VEGF for angiogenesis. (A) Western blot analysis of VEGF, AKT, p-AKT and β-actin was assessed in the homogenate mixture prepared from the wound skin using the specific primary antibodies. (B) Value was defined as 1 (Vehicle-treated group) for the acquisition of other relative values. Data represents the means±SD from three replicates. \*P\<0.05 relative to the Vehicle-treated group; ^\#^P\<0.05 relative to the level of the MFLB group, ^§^P\<0.05 relative to the LoBSLB group. BSLB, liquid bandage; MFLB, medifoam liquid bandage; LoBSLB, low concentration BSLB; HiBSLB, high concentration BSLB.](MMR-19-01-0452-g05){#f5-mmr-19-01-0452}

![Analysis of collagen-1 expression. (A) Western blot analysis of collagen-1 in the homogenate mixture prepared from the wound skin was evaluated using the specific primary antibody. The value was defined as 1 (Vehicle-treated group) for the acquisition of other relative values. Data represents the mean ± SD of three replicates. \*P\<0.05 relative to the Vehicle-treated group; ^\#^P\<0.05 relative to the level of the MFLB group; ^§^P\<0.05 relative to the LoBSLB group. (B) Immunohistochemistry of collagen protein. After BSLB treatment, the collagen-1 proteins were detected as a dense color around the dermis of re-epithelization region, when compared with the Vehicle-treated group. Histological alteration was observed around the re-epithelization region stained with specific antibody at magnification, ×100 and ×400 (left upper corner). BSLB, liquid bandage; MFLB, medifoam liquid bandage; LoBSLB, low concentration BSLB; HiBSLB, high concentration BSLB.](MMR-19-01-0452-g06){#f6-mmr-19-01-0452}

![Evaluation of hepatotoxicity of BSLB application. (A) Liver tissue of Sprague Dawley rats was prepared on a histological slide, and cellular morphology was viewed at magnification, ×400. (B) Blood was collected from the abdominal veins of Vehicle and the two BSLB-treated Sprague Dawley rats. Serum concentrations of ALP, AST and ALT were analyzed in duplicate using a serum biochemical analyzer. Data represents the mean ± SD from three replicates. BSLB, liquid bandage; MFLB, medifoam liquid bandage; LoBSLB, low concentration BSLB; HiBSLB, high concentration BSLB; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase.](MMR-19-01-0452-g07){#f7-mmr-19-01-0452}

![Evaluation of nephrotoxicity of BSLB application. (A) Kidney tissue of Sprague Dawley rats was prepared on a histological slide, and cellular morphology was viewed at magnification, ×400. (B) Blood was collected from the abdominal veins of Vehicle and the two BSLB-treated Sprague Dawley rats. Serum concentrations of BUN and CREA were analyzed in duplicate, using a serum biochemical analyzer as described in the Materials and Methods. Data represents the mean ± SD from three replicates. \*P\<0.05 relative to the Vehicle-treated group; ^\#^P\<0.05 relative to the level of the MFLB group; ^§^P\<0.05 relative to the LoBSLB group. BSLB, liquid bandage; MFLB, medifoam liquid bandage; LoBSLB, low concentration BSLB; HiBSLB, high concentration BSLB; BUN, blood urea nitrogen; CREA, creatinine.](MMR-19-01-0452-g08){#f8-mmr-19-01-0452}
